BACKGROUND/ OBJECTIVES: The aim of the present study was to assess the long-term predictive value of myocardial perfusion imaging (MPI) with (13)N-ammonia positron emission tomography (PET) in patients with suspected myocardial perfusion abnormality. At present, outcome data on the predictive value of MPI in (13)N-ammonia PET exist only for rather small patient populations. METHODS: Cardiac perfusion was assessed in 943 consecutive patients using (13)N-ammonia PET, and follow-up was obtained in 698 (74%). 77 patients who underwent early revascularization (<60 days) were excluded and 621 patients were assigned to normal versus abnormal perfusion for outcome analysis. Hard events (cardiac death and non-fatal myocardial infarction) and major adverse cardiac events (MACE; hard events, hospitalization for cardiac reasons and late revascularization) were investigated using the Kaplan-Meier method. Independent predictors for various cardiac events were identified using Cox proportional hazard regression analysis. RESULTS: During follow-up (5.7 ± 2.5 years), 275 patients had at least 1 cardiac event, including 102 cardiac deaths and 33 non-fatal myocardial infarction. Abnormal perfusion (n=469) was associated with a higher incidence of MACE (P<0.001) and hard events (P<0.001) throughout the 10-year follow-up period. CONCLUSIONS: Cardiac perfusion findings in (13)N-ammonia PET are strong predictors of long-term outcome.
BACKGROUND/ OBJECTIVES: The aim of the present study was to assess the long-term predictive value of myocardial perfusion imaging (MPI) with (13)N-ammonia positron emission tomography (PET) in patients with suspected myocardial perfusion abnormality. At present, outcome data on the predictive value of MPI in (13)N-ammonia PET exist only for rather small patient populations. METHODS: Cardiac perfusion was assessed in 943 consecutive patients using (13)N-ammonia PET, and follow-up was obtained in 698 (74%). 77 patients who underwent early revascularization (<60 days) were excluded and 621 patients were assigned to normal versus abnormal perfusion for outcome analysis. Hard events (cardiac death and non-fatal myocardial infarction) and major adverse cardiac events (MACE; hard events, hospitalization for cardiac reasons and late revascularization) were investigated using the Kaplan-Meier method. Independent predictors for various cardiac events were identified using Cox proportional hazard regression analysis. RESULTS: During follow-up (5.7 ± 2.5 years), 275 patients had at least 1 cardiac event, including 102 cardiac deaths and 33 non-fatal myocardial infarction. Abnormal perfusion (n=469) was associated with a higher incidence of MACE (P<0.001) and hard events (P<0.001) throughout the 10-year follow-up period. CONCLUSIONS: Cardiac perfusion findings in (13)N-ammonia PET are strong predictors of long-term outcome.
Authors: Venkatesh L Murthy; Timothy M Bateman; Rob S Beanlands; Daniel S Berman; Salvador Borges-Neto; Panithaya Chareonthaitawee; Manuel D Cerqueira; Robert A deKemp; E Gordon DePuey; Vasken Dilsizian; Sharmila Dorbala; Edward P Ficaro; Ernest V Garcia; Henry Gewirtz; Gary V Heller; Howard C Lewin; Saurabh Malhotra; April Mann; Terrence D Ruddy; Thomas H Schindler; Ronald G Schwartz; Piotr J Slomka; Prem Soman; Marcelo F Di Carli; Andrew Einstein; Raymond Russell; James R Corbett Journal: J Nucl Cardiol Date: 2018-02 Impact factor: 5.952
Authors: Caroline E Gebhard; Monika Marędziak; Angela Portmann; Susan Bengs; Ahmed Haider; Michael Fiechter; Bernhard A Herzog; Michael Messerli; Valerie Treyer; Ken Kudura; Elia von Felten; Dominik C Benz; Tobias A Fuchs; Christoph Gräni; Aju P Pazhenkottil; Ronny R Buechel; Philipp A Kaufmann; Catherine Gebhard Journal: Eur J Nucl Med Mol Imaging Date: 2019-06-28 Impact factor: 9.236
Authors: Ahmed Haider; Susan Bengs; Monika Maredziak; Michael Messerli; Michael Fiechter; Andreas A Giannopoulos; Valerie Treyer; Moritz Schwyzer; Christel Hermann Kamani; Dimitri Patriki; Elia von Felten; Dominik C Benz; Tobias A Fuchs; Christoph Gräni; Aju P Pazhenkottil; Philipp A Kaufmann; Ronny R Buechel; Catherine Gebhard Journal: Eur J Nucl Med Mol Imaging Date: 2019-01-16 Impact factor: 9.236
Authors: Abdel K Tahari; Andy Lee; Mahadevan Rajaram; Kenji Fukushima; Martin A Lodge; Benjamin C Lee; Edward P Ficaro; Stephan Nekolla; Ran Klein; Robert A deKemp; Richard L Wahl; Frank M Bengel; Paco E Bravo Journal: Eur J Nucl Med Mol Imaging Date: 2013-08-28 Impact factor: 9.236
Authors: Catherine Gebhard; Michael Fiechter; Bernhard A Herzog; Christine Lohmann; Susan Bengs; Valerie Treyer; Michael Messerli; Dominik C Benz; Andreas A Giannopoulos; Christoph Gräni; Aju P Pazhenkottil; Ronny R Buechel; Philipp A Kaufmann Journal: Eur J Nucl Med Mol Imaging Date: 2018-05-19 Impact factor: 9.236